title: [Accesibility and tolerability on the use of subcutaneous hormone implants in a socially excluded population].
abstract: OBJECTIVE
  To determine the acceptability and tolerability of subcutaneous implants used in a socially excluded population from El Vacie, Seville.
  
  
  METHODS
  Prospective cohort study with follow-up.
  
  
  METHODS
  Pino Montano B Outpatient Department in Seville, Spain.
  
  
  METHODS
  A total of 66 females between 15-49 years who had a subcutaneous implant inserted, of whom 44.6% were from El Vacie (a shantytown outside Seville, Spain).
  
  
  METHODS
  Pre-implant questionnaire, placing of the implant and a post-implant questionnaire 3 months later.
  
  
  METHODS
  A study of the sociodemographic variables with frequency tables. Comparison of the tolerability with the place of residence variable (from El Vacie/not from El Vacie) using the Chi squared statistic, and the acceptability with frequency tables.
  
  
  RESULTS
  There were no statistically significant differences between the tolerability variables studied (P=.618), with a (relative risk) RR of 1.33 (0.430-4.134). The women not from El Vacie were less tolerant than the women from El Vacie. The great majority of women (93.1% El Vacie women and 88.9% non-El Vacie women) would come back to use this contraceptive method again after it expires in 3 years, and 84.7% of El Vacie women and 82.4% of those not from El Vacie considered the method as excellent.
  
  
  CONCLUSIONS
  Subcutaneous hormone implants were a safe, tolerable and accepted method with no cultural differences.
authors.affiliation: Centro de Salud Pino Montano B, Sevilla, España. vanessadub@hotmail.com
authors.forename: Vanessa Domínguez
authors.initials: VD
authors.lastname: Úbeda
authors.forename: Patricia Avila
authors.initials: PA
authors.lastname: Pecci
authors.forename: María Josefa Espinaco
authors.initials: MJ
authors.lastname: Garrido
authors.forename: José Román
authors.initials: JR
authors.lastname: Oliver
mesh_terms: D000293:Adolescent; D000328:Adult; D003271:Contraceptive Agents, Female / Q000008:administration & dosage*; D017135:Desogestrel / Q000008:administration & dosage*; D004343:Drug Implants; D005260:Female; D005500:Follow-Up Studies; D006297:Health Services Accessibility; D006801:Humans; D008875:Middle Aged; D010342:Patient Acceptance of Health Care; D011204:Poverty Areas; D011446:Prospective Studies; D013030:Spain; D055815:Young Adult
chemical_list: D003271:Contraceptive Agents, Female; D004343:Drug Implants; C044815:etonogestrel; D017135:Desogestrel